The importance of tumour volume in the prognosis of radically treated periampullary carcinomas

Eur J Surg. 1993 Feb;159(2):95-100.

Abstract

Objective: To assess the influence of tumour volume on clinicopathological findings and survival time after radical operation for periampullary carcinoma.

Design: Retrospective study.

Setting: Kaiser-Franz-Josef-Hospital, Vienna, Austria.

Subjects: 72 of 75 consecutive patients who underwent pancreaticoduodenectomy for periampullary carcinoma between 1 January 1979 and 31 December 1991.

Outcome measures: Cancers were divided into four groups according to volume (mm3) and the incidence of lymph node involvement, infiltration of surrounding tissues and of visceral vessels, and histologically non-radical resections were calculated, as was the length of survival after resection.

Results: There were 22 tumours with a volume of 0-2500 mm3 (group 1), 12 with a volume of 2,501-5,000 mm3 (group 2), and 19 each in groups 3 (5,0001-10,000 mm3) and 4 (more than 10,000 mm3). All carcinomas of the common bile duct (n = 5) and the papilla of Vater (n = 18) were in groups 1 and 2, whereas 38 of the 49 carcinomas of the head of pancreas were in groups 3 and 4. Lymph nodes were involved in 3 (14%), 6 (50%), 13 (68%) and 14 (74%); the surrounding tissues were infiltrated in 6 (27%), 8 (67%), 11 (58%) and 12 (63%); the main visceral vessels were involved in 0, 3 (25%), 5 (26%) and 8 (42%); and the resections were histologically not radical in 0, 2 (17%), 7 (37%) and 9 (47%), respectively. There was significant negative correlation (p < 0.0001) between tumour mass and survival.

Conclusions: These results explain at least in part the poorer prognosis after radical resection of carcinoma of the head of the pancreas.

MeSH terms

  • Aged
  • Ampulla of Vater*
  • Common Bile Duct Neoplasms / mortality
  • Common Bile Duct Neoplasms / pathology*
  • Common Bile Duct Neoplasms / surgery*
  • Humans
  • Incidence
  • Lymphatic Metastasis
  • Middle Aged
  • Neoplasm Invasiveness
  • Pancreatic Neoplasms / mortality
  • Pancreatic Neoplasms / pathology*
  • Pancreatic Neoplasms / surgery*
  • Pancreaticoduodenectomy*
  • Prognosis
  • Retrospective Studies
  • Survival Rate